You are using an unsupported browser. Please update your browser to the latest version on or before July 31, 2020.
close
Home > 2020 Rare Drug Development Symposium > RARE Drug Development Symposium: Artificial Intelligence and Machine Learning for Rare Disease
RARE Drug Development Symposium: Artificial Intelligence and Machine Learning for Rare Disease
print icon

Dr. Annastasiah Mhaka, Dr. Swagatam Mukhopadhyay, and Dr. Harsha Rajasimha discuss the challenges and benefits of using artificial intelligence and machine learning in data research. While these tools can allow us to do more with less data, there are certain aspects of the research that cannot be duplicated by AI or ML.

 

Feedback
0 out of 0 found this helpful

scroll to top icon